We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NRC market cap is 359.89M. The company's latest EPS is USD 1.3193 and P/E is 11.72.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 37.95M | 38M | 35.31M | 35.02M | 35.82M |
| Operating Income | 9.96M | 11.71M | 8.76M | 8.87M | 7.98M |
| Net Income | 7.88M | 8.86M | 6.36M | 6.18M | 5.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.98M | 133.28M | 147.95M | 151.57M | 148.58M |
| Operating Income | 43.04M | 42.14M | 50.59M | 46.54M | 40.05M |
| Net Income | 32.41M | 37.26M | 37.47M | 31.8M | 30.97M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 120.14M | 122.44M | 120.91M | 119.1M | 131.8M |
| Total Liabilities | 62.26M | 73.48M | 83.97M | 78.9M | 97.18M |
| Total Equity | 57.87M | 48.96M | 36.95M | 40.2M | 34.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 110.69M | 133.42M | 157.54M | 130.46M | 122.44M |
| Total Liabilities | 77.79M | 69.11M | 72.2M | 58.43M | 73.48M |
| Total Equity | 32.89M | 64.32M | 85.34M | 72.03M | 48.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 26.41M | 38.11M | 12.04M | 18.82M | 28.25M |
| Investing | -12.01M | -15.78M | -4.14M | -9.41M | -15.84M |
| Financing | -35.6M | -40.71M | -12.85M | -15.58M | -15.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 40.92M | 40.64M | 46.34M | 36.27M | 38.11M |
| Investing | -4.66M | -3.72M | -8.51M | -9.84M | -15.78M |
| Financing | -36.35M | -15.5M | -18.16M | -55.58M | -40.71M |
| Market Cap | 359.89M |
| Price to Earnings Ratio | 11.72 |
| Price to Sales Ratio | 2.44 |
| Price to Cash Ratio | 54.55 |
| Price to Book Ratio | 7.41 |
| Dividend Yield | 3.13% |
| Shares Outstanding | 23.48M |
| Average Volume (1 week) | 89.12k |
| Average Volume (1 Month) | 101.77k |
| 52 Week Change | -61.89% |
| 52 Week High | 40.69 |
| 52 Week Low | 13.74 |
| Spread (Intraday) | 0.16 (1.04%) |
| Company Name | National Research Corporation |
| Address |
777 e wisconsin ave milwaukee, wisconsin 53202 5367 |
| Website | https://www.nrchealth.com |
| Industry | testing laboratories (8734) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
